Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2003
10/22/2003EP1353953A2 Mu-1, member of the cytokine receptor family
10/22/2003EP1353952A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
10/22/2003EP1353949A2 Compositions and methods relating to ovary specific genes and proteins
10/22/2003EP1353948A2 Soluble cyclic analogues of the beta amyloide peptide
10/22/2003EP1353940A2 Methods for producing and improving therapeutic potency of binding polypeptides
10/22/2003EP1353937A2 Specific human antibodies for selective cancer therapy
10/22/2003EP1353691A2 Molecular antigen array presenting amyloid beta
10/22/2003EP1353688A2 Method and compositions for immunization with the pseudomonas v antigen
10/22/2003EP0922059B1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
10/22/2003EP0659217B1 CLONING AND EXPRESSION OF beta APP-C100 RECEPTOR
10/22/2003CN1451044A Neutrokine－α和Neutrokine－α剪接变体 Neutrokine-α and Neutrokine-α splice variants
10/22/2003CN1451043A Dual specificity antibodies and methods of making and using
10/22/2003CN1450912A CD40 antagonists for use in treating psoriasis and other inflammatory skin conditions
10/22/2003CN1450911A New clinical parameters for determining hematologic toxicity proior to radioimmunotherapy
10/22/2003CN1450909A Monoclonal antibodies and antibody cocktail for detection of prion protein as an indiction of transmissible spongiform encephalopathies
10/22/2003CN1450908A Neurotoxic oligomers
10/22/2003CN1450907A Beta glycan as an inhibin receptor and uses thereof
10/22/2003CN1450086A Anti SARS specificity IgY and combination preparation thereof
10/22/2003CN1450065A Haptens, immunogens, and conjugates for 2-oxo-3-hydroxy LSD
10/22/2003CN1449833A Human SARS immune globulin
10/22/2003CN1449832A Horse SARS-resisting serum
10/22/2003CN1125178C Coding sequence of human serine/threonine kinase Ôàí its encoded polypeptide and preparing process
10/22/2003CN1125177C Coding Sequence of human short-chain alcohol dehydrogenase its encoded polypeptide and its preparing process
10/22/2003CN1125174C Recombinant phages
10/22/2003CN1125083C Monoclonal antibody active against CD44V6
10/22/2003CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4
10/21/2003US6635752 Diagnosis of Aids
10/21/2003US6635748 Protein for use as antitumor agent; for use as antimetastsis agent
10/21/2003US6635745 Rapamycin assay
10/21/2003US6635744 Substantially pure fibroblast growth factor homologous factor-4 polypeptide having specified amino acid sequence; diagnosis and treatment of neurodegenerative and neoplastic disorders
10/21/2003US6635743 Isolated antibody or portion that binds to protein selected from those having specified amino acid sequences or fragments; control apoptosis for treatment of autoimmune disease, graft versus host disease, rheumatoid arthritis and lymphadenopathy
10/21/2003US6635742 Antibodies specific for semaphorin-like polypeptides
10/21/2003US6635619 Amino acid sequence 88, 96, 97, 98, 99 or 100; increasing serum and tissue levels of active component
10/21/2003US6635483 Antisense polynucleotide targeted to a nucleic acid encoding the gene, thereby suppressing its expression; cDNA encapsulated in liposome; use as antitumor, anticarcinogenic or antiapoptotic; Alzheimer's disease
10/21/2003US6635482 Produced by hybridoma; cytokines; useful in diagnosis, prevention and treatment of immune system-related disorders
10/21/2003US6635479 Hypothalamus-specific polypeptides
10/21/2003US6635476 Complex of recombinant virus-chelating peptide covalently linked to ligand through a transition metal ion; kinetically stable; use in delivering a therapeutic or diagnostic agent to a cell
10/21/2003US6635473 Isolated nucleic acid encoding a fibrinogen-binding protein; useful in prevention, diagnosis and treatment of infections; can be administered to wounds or for coating prosthetics to inhibit binding of the bacteria
10/21/2003US6635468 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/21/2003US6635461 Encoded by isolated nucleic acid; has glycosyltransferase activity; given amino acid sequence; useful as diagnostic and therapeutic agent for cancer and thymus-related disorders
10/21/2003US6635442 Encoded by isolated DNA molecule; given amino acid sequence; useful for studying effects of chemical agents on coupled adenylate cyclase and hormone-sensitive lipases; use in controlling obesity, diabetes and hyperlipidemia
10/21/2003US6635434 Immunoassay for pesticides and their degradation products
10/21/2003US6635431 Recombinant lipolysis stimulated (LSR) comprising polypeptide of given sequence; use for selecting a compound for enhancing lipoprotein uptake in cells expressing the polypeptide
10/21/2003US6635429 Incubating a cell containing sequence linked to a DNA response element with an agent to determine its capability of transactivating the sequence; retinoic acid, thyroid, retinoid X
10/21/2003US6635424 Method for generating libraries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
10/21/2003US6635257 Oligomeric particle having diameter of 1 to 100 nanometer and consisting of hepatitis C virus envelope proteins, or parts thereof, in which at least one cysteine is alkylated
10/21/2003US6635256 Administering multiple domain glycoprotein hormones containing alpha subunit covalently linked to beta subunit to form single chain hormone and additional beta subunit noncovalently linked to tethered alpha subunit of single chain hormone
10/21/2003US6635255 CASB414:antigen overexpressed in several tumors
10/21/2003US6635252 Antibodies to superoxide dismutase-4
10/21/2003US6635250 Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus
10/21/2003US6635248 Isolated polypeptide consisting of single chain of amino acids comprising one or more penetrating fragments from one or more penetrating antibodies, which penetrates into cell
10/21/2003CA2182289C Immuno-stimulatory monoclonal antibodies
10/21/2003CA2157659C Use of porcine gal .alpha. (1,3) galactosyl transferase in xenograft therapies
10/21/2003CA2156825C Inhibition of intimal hyperplasia using antibodies to pdgf receptors
10/21/2003CA2132452C Casein kinase i-like protein kinase
10/21/2003CA2106962C Polypeptides from mycobacterium paratuberculosis
10/21/2003CA2076432C Humanized antibody derivatives that recognize difucosyl lewis blood group antigens y-6 and b-7-2
10/21/2003CA2053924C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
10/21/2003CA2017166C Metalloproteinase inhibitor
10/16/2003WO2003085399A1 Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor
10/16/2003WO2003085377A2 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003WO2003085124A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003WO2003085123A2 Methods anc compositions for in vivo clearance of pathogens
10/16/2003WO2003085119A1 METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO FcϜ RECEPTOR IIIa
10/16/2003WO2003085118A1 Process for producing antibody composition
10/16/2003WO2003085107A1 Cells with modified genome
10/16/2003WO2003085102A1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport
10/16/2003WO2003085096A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003WO2003085093A2 Antibodies that specifically bind to gmad
10/16/2003WO2003085089A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003WO2003085086A2 Motif-grafted hybrid polypeptides and uses thereof
10/16/2003WO2003085081A2 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer
10/16/2003WO2003084999A1 Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40
10/16/2003WO2003084998A1 Monoclonal antibody neutralizing megsin
10/16/2003WO2003084996A2 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine
10/16/2003WO2003084989A2 La1 - the genome of a lactobacillus strain
10/16/2003WO2003084574A1 Multivalent constructs for therapeutic and diagnostic applications
10/16/2003WO2003084570A1 DRUG CONTAINING ANTIBODY COMPOSITION APPROPRIATE FOR PATIENT SUFFERING FROM FcϜRIIIa POLYMORPHISM
10/16/2003WO2003084569A1 Drug containing antibody composition
10/16/2003WO2003084565A2 Ve-ptp as regulator of ve-cadherin mediated processes or disorders
10/16/2003WO2003084477A2 Mammalian cdr mimetibodies, compositions, methods and uses
10/16/2003WO2003073104A3 Diagnostic and therapeutic use of ma onconeuronal antigens for neurodegenerative diseases
10/16/2003WO2003068809A3 An herpes simplex virus complex
10/16/2003WO2003063792A8 Compositions and methods related to tim-3, a th1-specific cell surface molecule
10/16/2003WO2003059935A3 Methods for purifying protein
10/16/2003WO2003059282A3 Human monoclonal antibodies against cd30
10/16/2003WO2003054216A3 Antibodies that immunospecifically bind to trail receptors
10/16/2003WO2003052416A3 Focussed antibody technology
10/16/2003WO2003048321A3 Hybrid antibodies
10/16/2003WO2003046560B1 Self-assembly molecules
10/16/2003WO2003042368A3 Methods of expressing lim mineralization protein in non-osseous cells
10/16/2003WO2003040316A3 Selective elimination of cd52+ cells and uses thereof
10/16/2003WO2003037918A3 Pyranosone dehydratase from phanerochaete chrysosporium
10/16/2003WO2003035835A3 Glycoprotein compositions
10/16/2003WO2003029426A3 Human and murine cytokine polypeptides
10/16/2003WO2003029413A3 A novel g protein-coupled receptor, gave 10
10/16/2003WO2003028638A3 Treatment of uterine serous papillary cancer
10/16/2003WO2003027250A3 Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
10/16/2003WO2003014391A3 Method for the detection of a polymorphism in cpb2
10/16/2003WO2003012127A3 Assay for identifying inhibitors of hiv rt dimerization
1 ... 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 ... 1494